US 11464784
Inhibition of aminocylase 3 (AA3) in the treatment of cancer
granted A61KA61K31/18A61K31/26
Quick answer
US patent 11464784 (Inhibition of aminocylase 3 (AA3) in the treatment of cancer) held by The Regents of the University of California expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Oct 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/18, A61K31/26, A61K31/275, A61K31/352